alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 99.2

                                  CERTIFICATION

I, Edward F. Cooke, certify that:

1. I have reviewed this amendment to the annual report on Form 10-KSB/A of
Levcor International, Inc.; and

2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report.


Date: April 30, 2003


/s/ EDWARD F. COOKE
------------------------------
Edward F. Cooke,
Chief Financial Officer, Vice President, Secretary and Treasurer
**Exhibit21**

**Cephalon, Inc.**

**Subsidiaries**
| **Name**                                | ** ** | **Jurisdiction of Incorporation** |
|-----------------------------------------|------------|-----------------------------------|
| Anesta Corp.                            |       | Delaware                          |
| Anesta AG                               |       | Switzerland                       |
| Cell Therapeutics (UK) Limited          |       | United Kingdom                    |
| Cephalon (Bermuda) Limited              |       | Bermuda                           |
| Cephalon B.V.                           |       | The Netherlands                   |
| Cephalon Development Corporation        |       | Delaware                          |
| Cephalon Financiere Luxembourg S.a.r.l. |       | Luxembourg                        |
| Cephalon France SAS                     |       | France                            |
| Cephalon Europe SAS                     |       | France                            |
| Cephalon GmbH                           |       | Germany                           |
| Cephalon Holdings Limited               |       | United Kingdom                    |
| Cephalon International Holdings, Inc.   |       | Delaware                          |
| Cephalon Investments, Inc.              |       | Delaware                          |
| Cephalon Italia S.p.A.                  |       | Italy                             |
| Cephalon Limited                        |       | United Kingdom                    |
| Cephalon Luxembourg S.a.r.l             |       | Luxembourg                        |
| Cephalon Pharma ApS                     |       | Denmark                           |
| Cephalon Pharma GmbH                    |       | Germany                           |
| Cephalon Pharma (Ireland) Limited       |       | Ireland                           |
| Cephalon Pharma SL                      |       | Spain                             |
| Cephalon Sp.z.o.o.                      |       | Poland                            |
| Cephalon Technologies Partners, Inc.    |       | Delaware                          |
| Cephalon Technology, Inc.               |       | Delaware                          |
| Cephalon Titrisation                    |       | France                            |
| Cephalon (UK) Limited                   |       | United Kingdom                    |
| Cephalon Ventures Puerto Rico, Inc.     |       | Delaware                          |
| CIMA LABS INC.                          |       | Delaware                          |
| East End Insurance Ltd.                 |       | Bermuda                           |
| PolaRx Biopharmaceuticals, Inc.         |       | Delaware                          |
| Societe Civile Immobiliere Martigny     |       | France                            |
| Zeneus Pharma S.a.r.l.                  |       | France                            |

 

----
<PAGE>   1
                                   Exhibit 23




                          INDEPENDENT AUDITORS' CONSENT




We consent to the incorporation by reference in the Registration Statements of
Value City Department Stores, Inc. on Form S-8 (File Nos. 33-44207, 33-50198,
33-55348, 33-55350, 33-78586, 33-80588, 33-92966, 333-15957, 333-15961 and
333-66239) of our report dated April 5, 2000, appearing in the Annual Report on
Form 10-K405/A2 of Value City Department Stores, Inc. for the year ended January
29, 2000.



                                                 Deloitte & Touche  LLP



Columbus, Ohio
May 3, 2000














                                     E - 13
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 99-6957

LAWRENCE HUGHES,

Petitioner - Appellant,

versus

EDSEL T. TAYLOR, Warden; MACDOUGALL CORRECTIONAL INSTITUTION; CHARLES M. CONDON, Attorney General,

Respondents - Appellees.

Appeal from the United States District Court for the District of

South Carolina, at Charleston. Henry M. Herlong, Jr., District

Judge. (CA-98-1736-2-20AJ)

Submitted: September 30, 1999 Decided: October 15, 1999

Before WIDENER, LUTTIG, and MICHAEL, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Lawrence Hughes, Appellant Pro Se. Donald John Zelenka, Chief

Deputy Attorney General, Columbia, South Carolina, for Appellees.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
* We note, however, that the district court’s dismissal is

without prejudice to Hughes’ right to file in this court an

appropriate petition pursuant to 28 U.S.C.A. § 2244 (West Supp.

1999).

2

PER CURIAM:

Lawrence Hughes appeals the district court’s order denying

relief on his petition filed under 28 U.S.C.A. § 2254 (West 1994 &

Supp. 1999). We have reviewed the record and the district court’s

opinion accepting the recommendation of the magistrate judge and

find no reversible error. Accordingly, we deny a certificate of

appealability and dismiss the appeal substantially on the reasoning

of the district court. See Hughes v. Taylor, No. CA-98-1736-20AJ

(D.S.C. June 22, 1999).* We dispense with oral argument because

the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional

process.

DISMISSED
### SANTA BARBARA COUNTY

AIR POLLUTION CONTROL DISTRICT

NOTICE OF BOARD HEARING



### Proposed Amended Rule 339

Motor Vehicle and Mobile E quipment Coating Operations

Thursday, June 19, 2008 – Approximately 1:30 p.m. Santa Barbara Board of Supervisors’ Hearing Room 105 East Anapamu Street, Santa Barbara, CA

The Santa Barbara County Air Pollution Control District (APCD) Board of Directors will hold a public hearing at the time and location listed above to accept comments and consider adoption of amended Rule 339.

Sources Potentially Affected This amended rule affects any person w ho sells, specifies the use of, offers for sale or applies coati ngs for the purpose of finishing or refinishing motor vehicles, mobile equipment and thei r exterior parts and components.

About the Proposed Amended Rule Rule 339 will be amended to adopt the provisions of the California Air Resources Board’s (CARB’s) Suggested Control Measure for Automotive Refinish Coatings . The amended rule will include new control techniques to

reduce solvent emissions. The most significant components of this rule revision involve: separate volatile organic compound (VOC) limits for clear and color coatings (color coat VOC limit of 420 grams per liter); simplified and combined coating categories, and a 25 gram per liter VOC limit for most cleaning solvents. Most elements of the amended rule will take effect on January 1, 2009. For more informati on regarding this rule revision and suggested control measure plea se see the APCD website ( www.sbcapcd.org ) and the CARB website ( www.arb.ca.gov/coatings/a utorefin/scm/scm.htm ).

The 2001, 2004 and 2007 Clean Air Plans identified the need to incorporate

the Suggested Control Measures fo r Automotive Refinish Coatings recently adopted by the state (CARB).

The APCD has determined that the propos ed revisions to this rule will not cause new significant effects which we re not addressed in the 1991 Air Quality Attainment Plan Environmen tal Impact Report and the 2007 Clean Air Plan Supplemental Environmental Impact Report. Any subsequent changes to the project description w ill require additi onal environmental

review.

Copies of the proposed rules may be reviewed on the APCD’s web site, www.sbcapcd.org/notices.htm , or at the following locations:

APCD APCD 260 N. San Antonio Rd, 301 E. Cook Street,

Suite A Suite L Santa Barbara, CA 93110 Santa Maria, CA 93454 (805) 961-8800 (805) 961-8800

Copies may also be obtained by c ontacting Liz Zavala at 805.961.8811.

Please send written comments to Re becca Armstrong (805.961.8888) via

email to ArmstrongR@sbcapcd.org , or via regular mail to the APCD at the

Santa Barbara address listed above.

Published Sunday, May 18, 2008
Exhibit 10.8



OSHKOSH B'GOSH, INC.
1995 OUTSIDE DIRECTORS' STOCK OPTION PLAN
(INCLUDING AMENDMENTS MADE 7/30/02)







1. "Board" shall mean the Board of Directors of the Company.
2. "Company" shall mean Oshkosh B'Gosh, Inc., a Wisconsin corporation.
3. "Company Stock" shall mean the Company's Class A Common Stock and such other stock and securities as may be substituted therefor pursuant to Section 3.02.
4. "Director" shall mean a director of the Company.
5. "Fair Market Value" on any date shall mean, with respect to Company Stock, if the stock is then listed and traded on a registered national securities exchange, or is quoted in the NASDAQ National Market System, the mean of the high and low sale prices recorded in composite transactions as reported by a reliable source for such date.  In the absence of reported sales or if the stock is not so listed or quoted, but is traded in the over-the-counter market, Fair Market Value shall be the mean of the closing bid and asked prices for such shares on the relevant date.
6. "Grantee" shall mean any person who has been granted an option under the Plan.
7. "Outside Director" shall mean a Director who is not also an active full-time employee of the Company or a corporation in which the Company owns, directly or indirectly, a voting stock interest of more than fifty percent (50%).







1. Annual Grant
2. Special Rule
**Exhibit
        32.2**
 
 **CERTIFICATION
        PURSUANT TO**
 **18
        U.S.C. SECTION 1350,**
 **AS
        ADOPTED PURSUANT TO**
 **SECTION
        906 OF THE SARBANES-OXLEY ACT OF 2002**
 
 In
        connection with the Annual Report of Sunrise Energy Services, Inc. a Delaware
        corporation (the “Company”) on Form 10-KSB/A for the period ending December 31,
        2005, as filed with the Securities and Exchange Commission on the date hereof
        (the “Report”), Konstantin Tsirulnikov, Vice President and Chief Financial
        Officer of the Company, certifies to the best of his knowledge, pursuant
        to
        18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
        2002, that:
 
 (1)
              The
                  Report fully complies with the requirements of Section 13(a) or
                  15(d) of
                  the Securities Exchange Act of 1934; and
 
 (2)
              The
                  information contained in the Report fairly presents, in all material
                  respects, the financial condition and result of operations of the
                  Company.
 
 A
        signed
        original of this written statement required by Section 906 has been provided
        to
        Sunrise Energy Services, Inc., and will be retained by Sunrise Energy Services,
        Inc. and furnished to the Securities and Exchange Commission or its staff
        upon
        request.
 
 Date:
                  February 6, 2007By:
              /s/
                  Konstantin TsirulnikovKonstantin
                  TsirulnikovChief
                  Financial Officer
NOT FINAL UNTIL TIME EXPI RES TO FILE REHEARING MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL OF FLORIDA SECOND DISTRICT

JOSE MARES, ) ) Appellant, ) ) v. ) Case No. 2D13-2731 ) STATE OF FLORIDA, ) ) Appellee. ) ) Opinion filed May 6, 2015.

A ppeal from the Circuit Court for Manatee County; John F. Lakin, Judge. Howard L. Dimmig, II, Public Defender, and Maureen E. Surber, Assistant Public Defender, Bartow, for Appellant. Pamela Jo Bondi, Attorney General, Tallahassee, and Bilal A. Faruqui, Assistant A ttorney General, Tampa, for Appellee.

CASANUEVA, Judge. Jose Mares appeals the summary denial of his motion filed purs uant to Florida Rule of Criminal Procedure 3.800(a). Mr. Mares alleged in his motion that he received a mandatory sentence of life in prison without the pos sibility of parole for a first-degree murder that he committed when he was sixteen years old. The motion was denied based on Geter v. State, 115 So. 3d 375 (Fla. 3d DCA 201 2), and Gonzalez v.- 2 - State, 101 So. 3d 886 (Fla. 1st DCA 2012), which held that Mill er v. Alabama, 132 S. Ct. 2455 (2012), did not apply retroactively. The Florida Supreme Court has recently held that the Miller decision applies retroactively to all juvenile offenders whose convictions

and sentences were final when Mill er was decided. Falcon v. St ate, 40 Fla. L. Weekly S151, S151 (Fla. Mar. 19, 2015). Accordingly, we reverse the p ostconviction court's order summarily denying the claim. We note that the Florida Supreme Court has further held in Hor sley v. State, 40 Fla. L. Weekly S155, S155 (Fla. Mar. 19, 2015), that the proper remedy in cases involving juvenile offenders whose sentences are unconsti tutional under Miller is to apply chapter 2014–220, Laws of Florida. The court conclude d that "applying chapter 2014–220, Laws of Florida, to all juvenile offenders whose sent ences are unconstitutional under Miller is the remedy most faithful to th e Eighth Amendment principles established by the United States Supreme Court, to t he intent of the Florida Legislature, and to the doctrine of separation of powers." Id. at S160. The relevant provisions of chapter 2014–220 have been codified in sections 7 75.082, 921.1401, and 921.1402, Florida Statutes (2014). A ccordingly, we reverse the order denying Mr. Mares' motion and remand for a resentencing proceeding consiste nt with this new juvenile sentencing legislation. See Horsley, 40 Fla. L. Weekl y S155; Falcon, 40 Fla. L. Weekly S151.

Reversed and remanded with directions.

WALLACE and KHOUZAM, JJ., Concur.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed).                    

*Date:*                         October 10, 2024.                    

*Time:*                         11:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, 3G58, Rockville, MD 20892 (Video Assisted Meeting).                    

*Contact Person:*                         Anuja Mathew, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G58, Rockville, MD 20892, 301-761-6911,                         *anuja.mathew@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

      ( print page 76124)    
Dated: September 11, 2024.

Lauren A. Fleck,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2024-21024 Filed 9-16-24; 8:45 am]

BILLING CODE 4140-01-P
<PAGE>   1

                                                                   EXHIBIT 10.28

                                FIRST ADDENDUM TO
                        LICENSE AND DEVELOPMENT AGREEMENT
                         FOR SPECIFIC MEDICAL TECHNOLOGY
                    FOR THE DETECTION OF ONCOGENIC HPV VIRUS

         This is a First Addendum to the License and Development Agreement for
Specific Medical Technology for the Detection of Oncogenic HPV Virus dated June
23, 2000 ("License and Development Agreement") by and between INVIRION, a United
States corporation organized and existing under the laws of the State of
Illinois, having a place of business at 2350 Pilgrim Highway, Frankfort,
Michigan 49635 ("Invirion") and AMPERSAND MEDICAL CORPORATION, a Delaware
corporation, having a place of business at 414 North Orleans, Chicago, Illinois
60610 ("Ampersand").

         Except to the extent modified by this First Addendum, the License and
         Development Agreement is hereby reaffirmed.

         The License and Development Agreement is hereby modified by
incorporating into it the following agreement between the parties:

         1. The $100,000 payment for the License and Development Agreement
(now past due) and $150,000 payment now due as a result of Invirion meeting the
benchmark set forth in Paragraph 3.1(2), shall not be made payable immediately,
but rather, converted into ten (10) installment payments of $25,000 per month
with the first payment due on September 11, 2000.

         2. In exchange for the change in payment terms, Ampersand agrees to the
following:
            a. On September 11, 2000 Ampersand will issue to Invirion the
               warrant for 150,000 shares of Ampersand stock as set forth in
               Exhibit B and also issue to Invirion a similar warrant for
               100,000 additional shares of Ampersand stock.


<PAGE>   2


            b. The timeline for steps 4-7 set forth in Exhibit AD shall be
               extended to ten months from September 11, 2000.

            c. The timeline for steps 8-11 set forth in Exhibit AD shall be
               extended to 14 months from September 11, 2000.

            d. In the event the License and Development Agreement is terminated,
               all payments made to Invirion and all warrants issued to Invirion
               are non-refundable and all warrants are irrevocable and non-
               cancellable. Ampersand acknowledges that all payments and
               issuance of warrants to Invirion are for services already
               performed by Invirion prior to such payment or issuance of the
               warrant.

         IN WITNESS WHEREOF, the parties hereto have caused to be signed, by
their duly authorized officers, this First Addendum of the License and
Development Agreement originally dated June 23, 2000, on the dates set forth
below.


INVIRION CORPORATION                        AMPERSAND MEDICAL CORPORATION

BY:_______________________________          BY: _____________________________

DATED:____________________________          DATED: __________________________
Date: October 7, 2014

Memo to: Docket ID# EPA

- HQ

- OAR

- 2009

- 0734

From: David Cole, U.S. Environmental Protection Agency

S ubject: Proposed Revisions to Wood Heater NSPS

– Telephone Conversation with Tomás

Carbonell , Environmental Defense Fund (EDF)
On October 7, 2014, r epresentatives of the U.S. Environmental Protection Agency m et by telephone with Tomás Carbonell , EDF , at his request. The purpo se of the meeting was for Mr. Carbonell to express EDF ’ s concerns about several provisions of the proposed standards as the Agency continues to develop the final rule.

S pecific areas of concern were the following: 1. Cord wood testing for compliance, including j oint recommendations from NESCAUM, WESTAR an d HPBA on cord wood testing , dated August 18, 2014 (see http://www.regulations.gov/#!documentDetail;D=EPA

- HQ

- OAR

- 2009

- 0734

- 1712 )

2. Hydronic heaters , proposed emissions standards

3. Need for h angtags

4. Data to support proposed standards for f orced

- air f urnaces
Attending the meeting were —

EDF : Tomás Carbonell EPA/OAQPS: Gregory Green, Chebryll Edwards, Gil Wood, Amanda Aldridge, David Cole
1

Date: May 21, 2015

Subject: Minutes of the May 21, 2015 meeting with representati ves of the Aerospace

Industries Association to discuss comments on proposed ame ndments to the Aerospace Manufacturing and Rework Facilities NESHAP

I. Introduction

A meeting with representatives of the Aerospace Industri es Association (AIA) and the aerospace industry was held with U.S. Environmental Protection Agenc y (EPA) staff on May 21, 2015. The purpose of the meeting was to discuss comments on the prop osed risk and technology review rule for Aerospace Manufacturing and Rework Facilities (40 CFR 63, subpart GG) published on February 17, 2015 (80 FR 8392). This memorandum summarizes the maj or topics discussed during the meeting.

II. Participants

Shannon Broome, Katten Munchin Rosenman (AIA) Chuck Knauss, Katten Munchin Rosenman (AIA) Carl Jacobsen, Lockheed Martin George Jung, Northrop Grumman Chris Santucci, Pratt & Whitney Dave Moore, Boeing Cheryl Myers, Delta Airlines Kim Teal, USEPA/OAQPS Ted Palma, USEPA/OAQPS Keith Barnett, USEPA/OAQPS Inez Pagan, USEPA/OAQPS Anne Pope, USEPA/OAQPS Kaye Whitfield, USEPA/OAQPS Brian Palmer, Eastern Research Group (ERG), Inc., co ntractor for the USEPA John Carter, ERG, Inc., contractor for the USEPA Jen Shweky, ERG, Inc., contractor for the USEPA

III. Discussion

The purpose of this meeting was to discuss AIA’s comments o n the aerospace rule and assess any potential needs to update or supplement the rulemaking record. AI A’s primary concerns revolved around the volume of comments from environmental NGOs (E NGOs) and their potential impact on the rule if EPA is sued by either industry or environme ntal groups. Overall, AIA stated they were pleased with the robustness and results of the an alysis EPA put into development of this rule.

AIA provided additional and/or clarifying statements on their comments on several aspects of the rule, including portions of both the risk analysis and the technology review. In response to the issues raised by AIA’s comments, EPA either accepted the input provided by AIA, asked questions to clarify or confirm EPA’s understanding of th e issue, or responded that EPA understood the comment and had no questions, and would respond in the supporting documents2

for the final version of the rule. In some cases, AIA offered to provide additional information to EPA to supplement the rulemaking record.